Clinical Trials Browser

Phase 2 × Relapsed Pediatric Solid Tumor × Erlotinib Hydrochloride × Clear all

NCT02638428 2020-03-19

Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy

Phase 2 Unknown

Other solid neoplasm

Relapsed Pediatric Solid Tumor